Latest UK accelerator cohorts: what founders are building now (refresh)
Latest UK Accelerator Cohorts: What Founders Are Building Now
The UK accelerator landscape remains intensely active. Across London, Manchester, Cambridge, and beyond, new cohorts are shipping products, closing seed rounds, and tackling problems that range from deeptech infrastructure to AI-powered operations. We've tracked the latest programmes—from tier-one names like Techstars and Startupbootcamp to regional players making meaningful bets on under-served ecosystems. Here's what founders are actually building.
The Big Cohorts: Where Capital and Talent Are Concentrating
The largest UK accelerators continue to attract outsized investment and founder attention, largely because they offer structured equity cheques, mentor networks, and demo day visibility that still matters for early-stage rounds.
Techstars London and the Applied Track
Techstars London's latest cohorts have shifted noticeably toward deeptech and climate. Rather than chase consumer apps, this year's batch includes founders building hardware supply chains, battery diagnostics, and net-zero manufacturing tooling. One standout: a team addressing UK semiconductor packaging bottlenecks—a space receiving heightened government attention post-Brexit and amid reshoring discussions.
The programme's mentor roster now includes corporate sponsors from heavy industry, not just venture partners, which signals a move toward founders solving 50-year legacy problems rather than optimising existing markets. Cohort sizes have stabilized around 10–15 companies per intake, deliberately smaller than pre-pandemic runs. Founders report the trade-off is real: less dilution pressure, more meaningful mentor time.
Founders Factory and the "Built-in-Britain" Focus
Founders Factory, the in-house accelerator model run by Founders, has expanded its remit beyond pure venture. Recent cohorts emphasize supply-chain resilience and industrial modernization—sectors where UK regulatory advantage and talent density (particularly in the Midlands and North) remain underexploited. A notable cohort includes robotics and logistics automation teams working on low-wage economy alternatives for manufacturing.
The equity model remains generous (typically £125k–£250k for ~10%), though recent cohorts have seen founders retain more board autonomy. This reflects founder feedback that earlier programmes felt overly prescriptive around fundraising trajectory.
Regional Acceleration: Outside the M25
Regional programmes have matured significantly. What once felt like secondary-tier acceleration now features competitive team density and founder commitment, partly because cost of living outside London allows programmes to attract international talent at lower salary expectations.
Techstars Manchester and Industrial Tech
Manchester's programme explicitly focuses on industrial decarbonization, advanced manufacturing, and logistics. Recent cohorts include teams building AI-driven energy management for factories, sustainable packaging alternatives, and supply-chain visibility tools. The geographic proximity to industrial heartland (Midlands, Yorkshire, Lancashire) means mentor access to operational decision-makers—not just investors—is markedly higher than equivalent London programmes.
What's notable: Manchester cohorts increasingly see exit paths within regional corporates and PE firms. A manufacturing AI founder from a recent cohort closed a £2.5m Series A led by a Midlands family office—rare five years ago, increasingly normal now.
Cambridge University Technology and Enterprise Club (CUTECh)
Cambridge's university-backed programme continues to pump out deeptech companies, with particular strength in biotech, quantum computing, and advanced materials. Recent cohorts have benefited from deeper integration with university labs, giving founders genuine IP access without the overhead of standalone academic spin-outs.
The 2024 cohort includes several teams commercializing university-funded research into protein engineering, thermal storage, and quantum sensing. University backing provides regulatory credibility and often grants access to capital from research-focused funds (BGF, Parkwalk, Oxford Science Enterprises) that don't typically engage with non-academic founders.
Propel: Northern Powerhouse Tech
Propel, the Leeds-based accelerator backed by local authorities and private capital, has become a genuine alternative to South East concentration. Recent cohorts feature fintech, healthtech, and market infrastructure plays—areas where Northern founder density was historically low but is now approaching parity with London.
The programme's distinctive feature: embedded relationships with Northern healthcare trusts, local authorities, and retail corporates. This creates a different advantage than venture-heavy programmes—access to large customer contracts rather than rapid venture capital.
What Founders Are Actually Building: Sector Breakdown
Tracking recent cohort announcements and demo day presentations reveals clear sectoral trends, distinct from earlier-cycle UK acceleration where consumer and SaaS dominated.
Deeptech and Infrastructure
This is the moment. Recent cohorts across tier-one programmes feature 30–40% deeptech allocations—semiconductors, batteries, advanced materials, quantum computing, and climate tech. This reflects both founder conviction (many have science/engineering backgrounds and are explicitly avoiding consumer market saturation) and funder appetite driven by government initiatives around industrial resilience, net-zero commitments, and strategic autonomy.
Notable recent builds: thermal energy storage, novel battery chemistries, semiconductor testing automation, and fusion-adjacent plasma physics. Many of these companies are explicitly capital-intensive; programmes increasingly treat acceleration as part of a longer capital-raising journey rather than terminal funding.
AI and Automation (Still, But Differently)
AI companies haven't disappeared from cohorts—they've reoriented. Rather than general-purpose models or consumer chatbots, recent founders are building vertical SaaS on top of large language models, automation for specific regulated industries (legal, financial, manufacturing), and internal tools for enterprises. One recent cohort batch includes teams building AI for supply-chain optimization, regulatory compliance automation, and precision agriculture.
The AI quality bar has visibly risen. Generic prompt-wrapper businesses rarely get acceleration acceptance anymore. Programmes are looking for defensibility: proprietary data, vertical expertise, or integration depth that makes the product non-trivial to replicate.
Healthtech and Biotech
UK healthtech cohorts remain strong, especially around diagnostics, medical devices, digital health, and NHS-adjacent tooling. Recent programmes include teams building point-of-care diagnostics, precision medicine platforms, and clinical workflow software. The NICE regulatory pathway and NHS adoption mechanisms remain genuine advantages for UK-based founders, driving cohort investment even as venture funding to healthtech has contracted globally.
Fintech and Financial Infrastructure
After consolidation in 2022–2023, fintech acceleration has re-emerged around specific infrastructure gaps: embedded finance, B2B payments, post-trade infrastructure, and crypto/blockchain applications with genuine use cases (not speculation). Recent cohorts include teams building payment orchestration, neobank backends, and embedded lending platforms.
The regulatory environment—FCA-friendly relative to the US, but legitimately stringent—means fintech founders increasingly see acceleration programmes as part of compliance and credibility building, not just capital access.
Funding Patterns and Next Steps for Recent Cohort Companies
Recent cohort companies are raising differently than predecessors. The modal seed round remains £500k–£2m, but increasingly split into notes/safes rather than priced rounds. This allows companies to focus on product-market fit rather than valuation negotiation, particularly valuable when building deeptech with long development cycles.
Seed Round Dynamics
Funds backing recent cohort companies include established names (Atomico, Creandum, Pale Blue Dot) but also emerging UK-based vehicles specifically targeting post-accelerator investments. BGF, despite recent volatility in founder relations, remains a major cheque-writer for Manchester, Leeds, and Birmingham-based cohort companies.
Notably, corporate venture arms (Unilever Ventures, Boehringer Ingelheim, Shell Ventures) are increasingly present in cohort demo days, looking for early acquisition or partnership targets in sustainability, automation, and advanced manufacturing. This creates different exit optionality than pure venture paths.
Government Support and Non-Dilutive Funding
Recent cohort companies are sophisticated in layering government support alongside accelerator equity. Innovate UK grants (often £100k–£500k for R&D-stage companies) are increasingly paired with accelerator participation. SEIS/EIS tax incentives continue to structure early-stage fund raising, particularly from angel networks and regional family offices.
The Smart Grant and Innovate UK Loan programme remain underutilized by early-stage founders—many accelerators now include BEIS/UKRI relationship facilitation as part of the programme, since structured non-dilutive capital dramatically extends runway.
Accelerator Quality and Founder Selectivity
One genuine change: founders are increasingly selective about accelerator participation, rather than applying to maximum quantity. This reflects three factors:
- Equity cost visibility: Founders now understand that 10% dilution at £200k valuation (common structure) is materially different from 10% at £500k—programmes are increasingly transparent about this trade-off.
- Network skepticism: Mentorship and networking benefits are now evaluated rigorously; founders ask for referenceability and specific customer/investor introductions rather than generic mentorship credits.
- Stage mismatch: Accumulating evidence that accelerators work best for teams pre-product or very early product. Once founders have meaningful traction or external funding, accelerator dilution becomes harder to justify.
This has driven some programmes (notably Techstars and Founders Factory) to increase cheque sizes and reduce cohort frequency, acknowledging that quality of company and founder commitment matters more than throughput volume.
Key Takeaways for Founders Evaluating Acceleration Now
If you're considering an accelerator application in 2024–2025, here's the operator's view:
- Match programme thesis to your sector: A deeptech team gains disproportionately more from Techstars or Cambridge-linked programmes than generic London generalist acceleration. Regional match (Manchester for industrial tech, Cambridge for biotech) provides genuine mentor advantage.
- Evaluate the cheque size and valuation cap realistically: Work backward from your funding needs through Series A. A £200k accelerator cheque at £2m post-money might be appropriate for an unproven team; it's dilution you can't afford if you already have £500k in customer contracts.
- Audit the mentor network for relevance: Generic tech mentors are table stakes. Ask for introductions to customers, corporate partners, or investors in your specific vertical. If the programme can't provide 3–5 material introductions that your team couldn't generate independently, the networking value is overstated.
- Understand the follow-on fund optionality: Some programmes have affiliated follow-on funds or explicit LP relationships; others don't. Know whether you're betting on the programme's venture network or your own fundraising ability.
- Consider timing relative to product and customer traction: Acceleration is most valuable pre-product or very early product. If you have paying customers, the opportunity cost of three months on an accelerator programme often exceeds the capital and network benefits.
The Evolution Continues: What's Next for UK Acceleration
Several trends are reshaping the landscape:
Sector-specific programmes are proliferating. Rather than generalist cohorts, we're seeing climate-focused acceleration (Climate Angels, Pale Blue Dot), fintech-specific programmes (Entrepreneur First's financial services track), and biotech-specific vehicles. Specialization improves mentor relevance and founder peer quality.
Government-backed cohorts are increasing. Local authorities and development bodies are funding regional acceleration programmes more directly, sometimes with non-dilutive components. This is particularly evident in the Northern Powerhouse (Manchester, Leeds, Sheffield) and devolved nations.
Corporate intrapreneurship programmes are emerging. Large companies (Unilever, Shell, multinational pharmaceutical firms) are launching internal acceleration tracks, treating them as innovation pipelines rather than pure innovation theatre. These are creating different exit paths for founders.
Longer-term support models are replacing three-month sprints. Several programmes now offer 6–12 month engagement cycles, acknowledging that deeptech and meaningful product-market fit require more time than a standard demo day cycle.
The UK accelerator ecosystem has matured from cargo-cult replication of Y Combinator toward genuine regional differentiation. Founders now have real optionality: tier-one venture-focused acceleration in London, regional industrial programmes in Manchester and Leeds, university-backed deeptech in Cambridge, and increasingly specialized sector-specific vehicles.
The question isn't whether to accelerate—it's which programme aligns with your team, sector, stage, and capital strategy. The latest cohorts suggest that founders are asking those questions more rigorously than ever.
Useful Resources for Founders Exploring Acceleration
- Techstars London programme details and application
- UK government guidance on accelerators and support options
- FCA Start-up Hub for fintech and regulated business founders
- Innovate UK grant programmes and research funding
- BGF regional investment and acceleration support